Privacy: An Axiomatic Approach.

The increasing prevalence of large-scale data collection in modern society represents a potential threat to individual privacy. Addressing this threat, for example through privacy-enhancing technologies (PETs), requires a rigorous definition of what exactly is being protected, that is, of privacy itself. In this work, we formulate an axiomatic definition of privacy based on quantifiable and irreducible information flows. Our definition synthesizes prior work from the domain of social science with a contemporary understanding of PETs such as differential privacy (DP). Our work highlights the fact that the inevitable difficulties of protecting privacy in practice are fundamentally information-theoretic. Moreover, it enables quantitative reasoning about PETs based on what they are protecting, thus fostering objective policy discourse about their societal implementation.

Differentially Private Graph Neural Networks for Whole-Graph Classification.

Graph Neural Networks (GNNs) have established themselves as state-of-the-art for many machine learning applications such as the analysis of social and medical networks. Several among these datasets contain privacy-sensitive data. Machine learning with differential privacy is a promising technique to allow deriving insight from sensitive data while offering formal guarantees of privacy protection. However, the differentially private training of GNNs has so far remained under-explored due to the challenges presented by the intrinsic structural connectivity of graphs. In this work, we introduce a framework for differential private graph-level classification. Our method is applicable to graph deep learning on multi-graph datasets and relies on differentially private stochastic gradient descent (DP-SGD). We show results on a variety of datasets and evaluate the impact of different GNN architectures and training hyperparameters on model performance for differentially private graph classification, as well as the scalability of the method on a large medical dataset. Our experiments show that DP-SGD can be applied to graph classification tasks with reasonable utility losses. Furthermore, we apply explainability techniques to assess whether similar representations are learned in the private and non-private settings. Our results can also function as robust baselines for future work in this area.

Multi-omics data integration methods and their applications in psychiatric disorders.

To study mental illness and health, in the past researchers have often broken down their complexity into individual subsystems (e.g., genomics, transcriptomics, proteomics, clinical data) and explored the components independently. Technological advancements and decreasing costs of high throughput sequencing has led to an unprecedented increase in data generation. Furthermore, over the years it has become increasingly clear that these subsystems do not act in isolation but instead interact with each other to drive mental illness and health. Consequently, individual subsystems are now analysed jointly to promote a holistic understanding of the underlying biological complexity of health and disease. Complementing the increasing data availability, current research is geared towards developing novel methods that can efficiently combine the information rich multi-omics data to discover biologically meaningful biomarkers for diagnosis, treatment, and prognosis. However, clinical translation of the research is still challenging. In this review, we summarise conventional and state-of-the-art statistical and machine learning approaches for discovery of biomarker, diagnosis, as well as outcome and treatment response prediction through integrating multi-omics and clinical data. In addition, we describe the role of biological model systems and in silico multi-omics model designs in clinical translation of psychiatric research from bench to bedside. Finally, we discuss the current challenges and explore the application of multi-omics integration in future psychiatric research. The review provides a structured overview and latest updates in the field of multi-omics in psychiatry.